Susceptibility testing of Stenotrophomonas maltophilia to carbapenems

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 1, 1997, Pages 13-17

  Howe, R A ^a   Wilson, M P ^a   Walsh, T R ^b   Millar, M R ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; IMIPENEM; MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STENOTROPHOMONAS MALTOPHILIA;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONADACEAE; THIENAMYCINS;

EID: 0030813891     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.1.13     Document Type: Article

References (19)

1. Aoun, M., Van der Auwera, P., Devleeshouwer, C., Daneau, D., Seraj, N., Meunier, F. et al. (1992). Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centre. Journal of Hospital Infection 22, 307-16.
2. Victor, M. A., Arpi, M., Bruun, B., Jonsson, V. & Hansen, M. M. (1994). Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scandinavian Journal of Infectious Diseases 26, 163-70.
3. Maningo, E. & Watanakunakorn, C. (1995). Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. Journal of Infection 31, 89-92.
4. Pham, B. N., Aractingi, S., Dombret, H., Arlet, G., Hunault, M. & Degos, L. (1992). Xanthomonas (formerly Pseudomonas) maltophilia-lnduced cellulitis in a neutropenic patient. Archives of Dermatology 128, 702-4.
5. Vartovarian, S. E., Papadakis, K. A., Palacios, J. A., Manning, J. T. & Anaissie, E. J. (1994). Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum. Annals of Internal Medicine 121, 969-73.
6. Gladman, G., Connor, P. J., Williams, R. F. & David, T. J. (1992). Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Archives of Diseases in Childhood 67, 192-5.
7. Karpati, F., Malmborg, A. S., Alfredsson, H., Hjelte, L. & Strandvik, B. (1994). Bacterial colonisation with Xanthomonas maltophilia - a retrospective study in a cystic fibrosis patient population. Infection 22, 258-63.
8. Kropp, H., Gerckens, L., Sundelof, J. G. & Kahan, F. M. (1985). Antibacterial activity of imipenem: the first thienamycin antibiotic. Reviews of Infectious Diseases 7, Suppl. 3, S389-410.
9. British Society for Antimicrobial Chemotherapy Working Party. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
10. Akova, M., Bonfiglio, G. & Livermore, D. M. (1991). Susceptibility to β-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 β-lactamases. Journal of Medical Microbiology 35, 208-13.
11. Lecso-Bordet, M., Pierre, J., Sarkis-Karam, D., Lubera, S. & Bergogne-Berezin, E. (1992). Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistance mutants selected In vitro. Antimicrobial Agents and Chemotherapy 36, 669-71.
12. Wilcox, M. H., Winstanley, T. G. & Spencer, R. C. (1994). Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin. Journal of Antimicrobial Chemotherapy 33, 663-6.
13. Rahmati-Bahram, A., Magee, J. T. & Jackson, S. K. (1995). Growth temperature-dependent variation of cell envelope lipids and antibiotic susceptibility in Stenotrophomonas (Xanthomonas) maltophilia. Journal of Antimicrobial Chemotherapy 36, 317-26.
14. Edwards, J. R. & Turner, P. J. (1995). Laboratory data which differentiate meropenem and imipenem. Scandinavian Journal of Infectious Diseases Suppl. 96, 5-10.
15. Bonfiglio, G. & Livermore, D. M. (1991). Effect of media composition on the susceptibility of Xanthomonas maltophilia to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 28, 837-12.
16. Hawkey, P. M., Birkenhead, D., Kerr, K. G., Newton, K. E. & Hyde, W. A. (1993). Effect of divalent cations in bacteriological media on the susceptibility of Xanthomonas maltophilia to imipenem, with special reference to zinc ions. Journal of Antimicrobial Chemotherapy 31, 47-55.
17. Wheat, P. F., Winstanley, T. G. & Spencer, R. C. (1985). Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia. Journal of Clinical Pathology 38, 1055-8.
18. Elting, L. S., Khardori, N., Bodey, G. P. & Fainstein, V. (1990). Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infection Control and Hospital Epidemiology 11, 134-8.
19. Villarino, M. E., Stevens, L. E., Schable, B., Mayers, G., Miller, J. M., Burke, J. P. et al. (1992). Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infection Control and Hospital Epidemiology 13, 201-6.